DIN 02475774 — JULUCA 50 MG; 25 MG
JULUCA is a tablet of Dolutegravir / Rilpivirine marketed by VIIV HEALTHCARE ULC. The full Dolutegravir / Rilpivirine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02475774
- Brand name
- JULUCA
- Active ingredient
- Dolutegravir / Rilpivirine
- Strength
- 50 MG; 25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- VIIV HEALTHCARE ULC
- Health Canada status
- MARKETED
- Drug class
- Integrase strand transfer inhibitor (INSTI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) combination (antiretroviral)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.